Caribou Biosciences, Inc. CRBU
NASDAQ · United States · Health Technology
$1.220.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.24 | -0.32 | +25.9% | $1.50M | -34.2% | -7.1%$1.70→$1.58 |
| Q1 2026 | 2026-05-07 | -0.26 | -0.33 | +21.2% | — | — | -0.5%$1.95→$1.94 |
| Q4 2025 | 2026-03-05 | -0.28 | -0.32 | +12.5% | — | — | +1.1%$1.80→$1.82 |
| Q3 2025 | 2025-11-12 | -0.30 | -0.36 | +16.7% | — | — | -11.4%$2.24→$1.99 |
| Q2 2025 | 2025-08-12 | -0.35 | -0.42 | +16.7% | — | — | — |
| Q4 2024 | 2025-03-10 | -0.39 | -0.40 | +2.5% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.38 | -0.45 | +15.6% | — | — | — |
| Q2 2024 | 2024-08-06 | -0.44 | -0.44 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.